Company Monitoring Page for JNJ

latest headlines for company on cafepharma

Pursuing AbbVie and J&J, Innovent hits primary endpoint in phase 2 psoriasis trial
Fierce Biotech
Wed, 08/10/22 - 10:49 am
Tags:
Innovent, AbbVie, JNJ, monoclonal antibodies, psoriasis, clinical trials
Johnson & Johnson And Hospital Giant HCA To Tackle Health Equity
Forbes
Tue, 08/9/22 - 10:35 am
Tags:
JNJ, HCA Healthcare, health equity
AI innovation among clinical trial companies dropped in the past quarter
Clinical Trials Arena
Mon, 08/8/22 - 10:05 am
Tags:
clinical trials, artificial intelligence, JNJ, patents
J&J nabs label expansion for Stelara in pediatric psoriatic arthritis
Endpoints
Tue, 08/2/22 - 12:03 am
Tags:
JNJ, Stelara, pediatric, psoriatic arthritis
Johnson & Johnson isn't finished with Emergent dispute, files arbitration demand
Fierce Pharma
Mon, 08/1/22 - 11:56 pm
Tags:
JNJ, Emergent BioSolutions, vaccines, COVID-19, legal
Lilly, AZ, AbbVie and J&J face big potential hit from Medicare pricing bill: analysts
Fierce Pharma
Mon, 08/1/22 - 10:53 am
Tags:
Eli Lilly, AstraZeneca, JNJ, AbbVie, legislation, drug pricing, Medicare
Go or no go? J&J’s bispecific FDA first
EP Vantage
Thu, 07/28/22 - 11:04 am
Tags:
JNJ, Amicus Therapeutics, Acadia Pharma, Bluebird Bio, FDA
J&J partner Legend Biotech looks to raise $250M amid Carvykti rollout, global expansion
Fierce Pharma
Wed, 07/27/22 - 10:28 am
Tags:
JNJ, Legend Biotech, Carvykti, CAR-T
J&J looks to expand Rybrevant lung cancer indication to larger EGFR-positive population
Endpoints
Tue, 07/26/22 - 11:03 am
Tags:
JNJ, Rybrevant, lung cancer, non-small cell lung cancer
J&J Strengthens Its Stronghold in Medtech
Medical Devices and Diagnostics Industry
Mon, 07/25/22 - 10:40 am
Tags:
JNJ, earnings, Medtech, devices
Johnson & Johnson beats on Q2 earnings, cuts forecast
Yahoo Finance
Tue, 07/19/22 - 09:57 pm
Tags:
JNJ, earnings
Medtech research spending set to slow in 2022
EP Vantage
Tue, 07/5/22 - 10:57 am
Tags:
Medtech, R&D, Abbott Labs, Becton Dickinson, Boston Scientific, EssilorLuxottica, JNJ, Medtronic, Philips, Roche, Siemens Healthineers, Stryker
Janssen secures FDA breakthrough designation for myeloma therapy
Pharmaceutical Business Review
Thu, 06/30/22 - 10:54 am
Tags:
JNJ, Janssen, breakthrough therapy, FDA, talquetamab, Multiple Myeloma, relapsed or refractory multiple myeloma
Big pharma’s key third-quarter data
EP Vantage
Tue, 06/28/22 - 10:37 am
Tags:
GSK, Roche, Pfizer, JNJ, AstraZeneca, Novo Nordisk vaccines, clinical trials, pneumococcal disease, crovalimab, rheumatoid arthritis
J&J Develops Contacts to Address Digital Eye Strain
Medical Devices and Diagnostics Industry
Mon, 06/20/22 - 08:19 pm
Tags:
JNJ, Medtech, digital eyestrain
Janssen Recruiting for Phase III Trials of Potential Myasthenia Gravis Game Changer
BioSpace
Mon, 06/20/22 - 10:57 am
Tags:
Janssen, JNJ, clinical trials, nipocalimab, myasthenia gravis
Did J&J and BMS conspire on blood thinner price hikes? Congressional leaders want DOJ, FTC to look into it: report
Fierce Pharma
Tue, 06/14/22 - 08:57 pm
Tags:
JNJ, Xarelto, Bristol Myers Squibb, Eliquis, drug pricing, blood thinners, FTC
J&J jumps onto Evotec’s receptor platform in drug discovery deal
Fierce Biotech
Tue, 06/14/22 - 11:17 am
Tags:
JNJ, Evotec, drug discovery, TargetAlloMod
7 Times Diabetes Tech Broke the Internet
Medical Devices and Diagnostics Industry
Sun, 06/12/22 - 08:28 pm
Tags:
Medtech, diabetes, Google, Medtronic, artificial pancreas, Beta Bionics, bionic pancreas, Fractyl Labs, JNJ, DexCom, continuous glucose monitoring, Abbott Labs, FreeStyle Libre
J&J, Emergent Accuse Each Other Of Violating COVID-19 Vaccine Deal
BioSpace
Tue, 06/7/22 - 11:54 pm
Tags:
JNJ, Emergent BioSolutions, COVID-19, vaccines

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.